{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T22:40:26Z","timestamp":1790030426661,"version":"4.0.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.mcna.2021.04.012","type":"journal-article","created":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T08:22:08Z","timestamp":1622190128000},"page":"783-797","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Common Cutaneous Infections"],"prefix":"10.1016","volume":"105","author":[{"given":"Ana","family":"Preda-Naumescu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boni","family":"Elewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany T.","family":"Mayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcna.2021.04.012_bib1","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1186\/s12879-015-1071-0","article-title":"Incidence of skin and soft tissue infections in ambulatory and inpatient settings, 2005-2010","volume":"15","author":"Miller","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.mcna.2021.04.012_bib2","series-title":"Medical microbiology","article-title":"Microbial infections of skin and nails","author":"Aly","year":"1996"},{"issue":"3","key":"10.1016\/j.mcna.2021.04.012_bib3","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1046\/j.0022-202x.2001.00043.x","article-title":"Skin microflora and bacterial infections of the skin","volume":"6","author":"Chiller","year":"2001","journal-title":"J\u00a0Investig Dermatol Symp Proc"},{"issue":"4","key":"10.1016\/j.mcna.2021.04.012_bib4","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.pop.2015.08.001","article-title":"Bacterial skin infections","volume":"42","author":"Ibrahim","year":"2015","journal-title":"Prim Care"},{"key":"10.1016\/j.mcna.2021.04.012_bib5","series-title":"Dermatology: an illustrated colour text","first-page":"50","article-title":"Bacterial infection \u2013 Staphylococcal and streptococcal","author":"Gawkrodger","year":"2017"},{"issue":"2","key":"10.1016\/j.mcna.2021.04.012_bib6","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1093\/cid\/ciu296","article-title":"Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America","volume":"59","author":"Stevens","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.mcna.2021.04.012_bib7","doi-asserted-by":"crossref","first-page":"S542","DOI":"10.1093\/cid\/cir170","article-title":"Efforts to support the development of fusidic acid in the United States","volume":"52","author":"Fernandes","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mcna.2021.04.012_bib8","series-title":"Treatment of skin disease: comprehensive therapeutic strategies","first-page":"139","article-title":"Cellulitis and erysipelas","author":"Heagerty","year":"2018"},{"issue":"6","key":"10.1016\/j.mcna.2021.04.012_bib9","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/BF01645222","article-title":"The course, costs and complications of oral versus intravenous penicillin therapy of erysipelas","volume":"12","author":"Jorup-R\u00f6nstr\u00f6m","year":"1984","journal-title":"Infection"},{"issue":"3","key":"10.1016\/j.mcna.2021.04.012_bib10","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1001\/jama.2016.8825","article-title":"Cellulitis","volume":"316","author":"Raff","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.mcna.2021.04.012_bib11","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/cid\/ciz004","article-title":"Current treatment options for acute skin and skin-structure infections","volume":"68","author":"Golan","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.mcna.2021.04.012_bib12","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1056\/NEJMoa055356","article-title":"Methicillin-resistant S. aureus infections among patients in the emergency department","volume":"355","author":"Moran","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.mcna.2021.04.012_bib13","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jamadermatol.2019.0884","article-title":"Assessment of antibiotic treatment of cellulitis and erysipelas","volume":"155","author":"Brindle","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"2","key":"10.1016\/j.mcna.2021.04.012_bib14","first-page":"37","article-title":"Complicated infections of skin and skin structures: when the infection is more than skin deep","volume":"53","author":"DiNubile","year":"2004","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.mcna.2021.04.012_bib15","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s11908-005-0010-4","article-title":"Skin manifestations of herpesvirus infections","volume":"5","author":"Toney","year":"2005","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.mcna.2021.04.012_bib16","series-title":"Treatment of skin disease: comprehensive therapeutic strategies","first-page":"337","article-title":"Herpes labialis","author":"Sterling","year":"2018"},{"key":"10.1016\/j.mcna.2021.04.012_bib17","first-page":"791","article-title":"Efficacy and safety of aciclovir mucoadhesive buccal tablet in immunocompetent patients with labial herpes (LIP trial): a double-blind, placebo-controlled, self-initiated trial","volume":"13","author":"Bieber","year":"2014","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"1","key":"10.1016\/j.mcna.2021.04.012_bib18","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12879-015-0824-0","article-title":"Effectiveness of topical corticosteroids in addition to antiviral therapy in the management of recurrent herpes labialis: a systematic review and meta-analysis","volume":"15","author":"Arain","year":"2015","journal-title":"BMC Infect Dis"},{"issue":"3","key":"10.1016\/j.mcna.2021.04.012_bib19","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1128\/AAC.47.3.1072-1080.2003","article-title":"High-dose, short-duration, early valacyclovir therapy for episodic treatment of cold sores: results of two randomized, placebo-controlled, multicenter studies","volume":"47","author":"Spruance","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mcna.2021.04.012_bib20","series-title":"Treatment of skin disease: comprehensive therapeutic strategies","first-page":"333","article-title":"Herpes genitalis","author":"Ramya","year":"2018"},{"issue":"5","key":"10.1016\/j.mcna.2021.04.012_bib21","doi-asserted-by":"crossref","first-page":"e341","DOI":"10.1016\/j.jemermed.2011.05.050","article-title":"Eczema herpeticum","volume":"43","author":"Hasegawa","year":"2012","journal-title":"J\u00a0Emerg Med"},{"issue":"3","key":"10.1016\/j.mcna.2021.04.012_bib22","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jemermed.2016.12.004","article-title":"Eczema herpeticum","volume":"53","author":"Cooper","year":"2017","journal-title":"J\u00a0Emerg Med"},{"key":"10.1016\/j.mcna.2021.04.012_bib23","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1067\/S0190-9622(03)00896-X","article-title":"Predisposing factors and clinical features of eczema herpeticum: a retrospective analysis of 100 cases","volume":"49","author":"Wollenberg","year":"2003","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.mcna.2021.04.012_bib24","first-page":"307","article-title":"Eczema herpeticum: a dermatologic emergency","volume":"14","author":"Mackley","year":"2002","journal-title":"Dermatol Nurs"},{"key":"10.1016\/j.mcna.2021.04.012_bib25","series-title":"Treatment of skin disease: comprehensive therapeutic strategies","first-page":"342","article-title":"Erythema multiforme","author":"Revuz","year":"2018"},{"key":"10.1016\/j.mcna.2021.04.012_bib26","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000249598","article-title":"Erythema multiforme -- response to corticosteroid","volume":"69","author":"Ting","year":"1984","journal-title":"Dermatologica"},{"key":"10.1016\/j.mcna.2021.04.012_bib27","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1365-2133.1993.tb00232.x","article-title":"Recurrent erythema multiforme: clinical features and treatment in a large series of patients","volume":"128","author":"Schofield","year":"1993","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.mcna.2021.04.012_bib28","first-page":"193","article-title":"Herpetic whitlow","volume":"79","author":"Wu","year":"2007","journal-title":"Cutis"},{"key":"10.1016\/j.mcna.2021.04.012_bib29","series-title":"Comprehensive medicinal chemistry II","first-page":"419","article-title":"Fungi and fungal disease","author":"Dorr","year":"2007"},{"issue":"10","key":"10.1016\/j.mcna.2021.04.012_bib30","doi-asserted-by":"crossref","first-page":"706","DOI":"10.31128\/AJGP-05-19-4930","article-title":"Superficial fungal infections","volume":"48","author":"Kovitwanichkanont","year":"2019","journal-title":"Aust J Gen Pract"},{"key":"10.1016\/j.mcna.2021.04.012_bib31","series-title":"Dermatology","first-page":"2231","article-title":"Antimicrobial drugs","author":"Carley","year":"2017"},{"key":"10.1016\/j.mcna.2021.04.012_bib32","series-title":"eTG complete","article-title":"Tinea","year":"2015"},{"issue":"7","key":"10.1016\/j.mcna.2021.04.012_bib33","article-title":"Oral antifungal medication for toenail onychomycosis","author":"Kreijkamp-Kaspers","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.mcna.2021.04.012_bib34","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1016\/S0190-9622(98)70490-6","article-title":"Once-weekly fluconazole (150, 300, or 450\u00a0mg) in the treatment of distal subungual onychomycosis of the toenail","volume":"38","author":"Scher","year":"1998","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.mcna.2021.04.012_bib35","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1067\/mjd.2000.109071","article-title":"Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis","volume":"43","author":"Gupta","year":"2000","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.mcna.2021.04.012_bib36","first-page":"887","article-title":"Patient considerations in the management of toe onychomycosis - role of efinaconazole","volume":"9","author":"LaSenna","year":"2015","journal-title":"Patient Prefer and Adherence"},{"key":"10.1016\/j.mcna.2021.04.012_bib37","series-title":"Janssen Pharmaceutical Companies. Grifulvin V (Griseofulvin Tablet, USP (Microsize) and Griseofulvin Oral Suspension, USP (microsize) [package insert]","year":"2011"},{"issue":"5","key":"10.1016\/j.mcna.2021.04.012_bib38","doi-asserted-by":"crossref","DOI":"10.1111\/dth.12545","article-title":"Topical antifungal treatment prevents recurrence of toenail onychomycosis following cure","volume":"30","author":"Shemer","year":"2017","journal-title":"Dermatol Ther"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002571252100050X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002571252100050X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:45:34Z","timestamp":1758419134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002571252100050X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S002571252100050X"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2021.04.012","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Common Cutaneous Infections","name":"articletitle","label":"Article Title"},{"value":"Medical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcna.2021.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}